Literature DB >> 26364198

Discovery of novel drug targets and their functions using phenotypic screening of natural products.

Junghwa Chang1, Ho Jeong Kwon2,3.   

Abstract

Natural products are valuable resources that provide a variety of bioactive compounds and natural pharmacophores in modern drug discovery. Discovery of biologically active natural products and unraveling their target proteins to understand their mode of action have always been critical hurdles for their development into clinical drugs. For effective discovery and development of bioactive natural products into novel therapeutic drugs, comprehensive screening and identification of target proteins are indispensable. In this review, a systematic approach to understanding the mode of action of natural products isolated using phenotypic screening involving chemical proteomics-based target identification is introduced. This review highlights three natural products recently discovered via phenotypic screening, namely glucopiericidin A, ecumicin, and terpestacin, as representative case studies to revisit the pivotal role of natural products as powerful tools in discovering the novel functions and druggability of targets in biological systems and pathological diseases of interest.

Entities:  

Keywords:  Drug discovery; Mode of action; Natural products; Phenotypic screening; Target identification

Mesh:

Substances:

Year:  2015        PMID: 26364198     DOI: 10.1007/s10295-015-1681-y

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  69 in total

Review 1.  Finding the target after screening the phenotype.

Authors:  Charles P Hart
Journal:  Drug Discov Today       Date:  2005-04-01       Impact factor: 7.851

2.  FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Authors:  T Kino; H Hatanaka; S Miyata; N Inamura; M Nishiyama; T Yajima; T Goto; M Okuhara; M Kohsaka; H Aoki
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

3.  FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

Authors:  T Kino; H Hatanaka; M Hashimoto; M Nishiyama; T Goto; M Okuhara; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

4.  The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.

Authors:  N Sin; L Meng; M Q Wang; J J Wen; W G Bornmann; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 5.  [Development of antituberculous drugs: current status and future prospects].

Authors:  Haruaki Tomioka; Kenji Namba
Journal:  Kekkaku       Date:  2006-12

6.  Metabolomic identification of the target of the filopodia protrusion inhibitor glucopiericidin A.

Authors:  Mitsuhiro Kitagawa; Satsuki Ikeda; Etsu Tashiro; Tomoyoshi Soga; Masaya Imoto
Journal:  Chem Biol       Date:  2010-09-24

7.  Target identification using drug affinity responsive target stability (DARTS).

Authors:  Brett Lomenick; Gwanghyun Jung; James A Wohlschlegel; Jing Huang
Journal:  Curr Protoc Chem Biol       Date:  2011-12-01

8.  A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function.

Authors:  Joong Sup Shim; Jiyong Lee; Hyun-Ju Park; So-Jung Park; Ho Jeong Kwon
Journal:  Chem Biol       Date:  2004-10

Review 9.  Genome-wide analysis of pancreatic cancer using microarray-based techniques.

Authors:  Tomohiko Harada; Claude Chelala; Tatjana Crnogorac-Jurcevic; Nicholas R Lemoine
Journal:  Pancreatology       Date:  2008-12-12       Impact factor: 3.996

10.  Reaction sites of rotenone, piericidin A, and amytal in relation to the nonheme iron components of NADH dehydrogenase.

Authors:  M Gutman; T P Singer; H Beinert; J E Casida
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

View more
  3 in total

1.  Building the basis for proteomics in personalized medicine for targeted treatment.

Authors:  Ho Jeong Kwon; Thomas E Fehniger; György Marko-Varga
Journal:  Clin Transl Med       Date:  2016-05-20

Review 2.  Molecular signaling mechanisms behind polyphenol-induced bone anabolism.

Authors:  Elisa Torre
Journal:  Phytochem Rev       Date:  2017-08-31       Impact factor: 5.374

3.  Natural products chemistry: The emerging trends and prospective goals.

Authors:  Riaz A Khan
Journal:  Saudi Pharm J       Date:  2018-02-07       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.